Evaluation of rapid diagnostic test kits for detection of Treponema pallidum antibody
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0303477 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Sirinart Chomean und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathum Thani, Thailand. Hauptthemen laut MEDLINE: Treponema pallidum, Syphilis, Reagent Kits, Diagnostic, Antibodies, Bacterial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thammasat University Research Unit in Medical Technology and Precision Medicine Innovation.
Abstract (Originalsprache)
Rapid syphilis testing plays a crucial role in global health strategies, addressing the urgent need for prompt and accurate diagnostics, especially in settings with limited resources. Despite their practical utility, these tests often lack thorough validation, leading to concerns about their efficacy and reliability. This study aims to evaluate two prototypes of the Onsite Syphilis Ab Combo Rapid Test (Fd and Ff) and compare their performance with the established chemiluminescent microparticle immunoassay (CMIA) method. Employing a reverse algorithm approach, the study analyzed 450 serum samples, including those from syphilis patients, healthy individuals, and cases with potential cross-reactions. Results of the rapid test kit were then correlated with CMIA findings, RPR, and TPPA titers. The results showed that prototype Fd exhibited a sensitivity of 100.0%, specificity of 98.8%, positive predictive value (PPV) of 8.4%, negative predictive value (NPV) of 100.00% and accuracy of 98.8%. Similarly, prototype Ff exhibited sensitivity of 100.0%, but with a slightly higher specificity of 99.6%, PPV of 21.5%, NPV of 100.0% and accuracy of 99.6%. Moreover, both prototypes Fd and Ff of the Onsite Syphilis Ab Combo Rapid Test demonstrated significant efficacy diagnostic tool, offering clear and straightforward interpretation for clinicians in varied CMIA, RPR and TPPA titer scenarios. The Onsite Syphilis Ab Combo Rapid Test prototypes, Fd and Ff, demonstrated high sensitivity and specificity, comparable to CMIA methods. The effectiveness highlights their suitability for syphilis screening, particularly in non-laboratory settings or situations requiring immediate results. The validation of these prototypes supports their integration into current syphilis diagnostic algorithms, potentially contributing to improved public health outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathum Thani, Thailand.
- Thammasat University Research Unit in Medical Technology and Precision Medicine Innovation, Thammasat University, Pathum Thani, Thailand.
- Medical Technology Laboratory, Thammasat University Hospital, Thammasat University, Pathum Thani, Thailand.
ORCID-Profile: Chollanot Kaset
Förderung
- Thammasat University Research Unit in Medical Technology and Precision Medicine Innovation
Zitieren
APA
Chomean, S., Puttaruk, P., Khamsophar, P., Fukpo, W., & Kaset, C. (2024). Evaluation of rapid diagnostic test kits for detection of Treponema pallidum antibody. PLOS ONE. https://doi.org/10.1371/journal.pone.0303477
Vancouver
Chomean S, Puttaruk P, Khamsophar P, Fukpo W, Kaset C. Evaluation of rapid diagnostic test kits for detection of Treponema pallidum antibody. PLOS ONE. 2024. doi:10.1371/journal.pone.0303477
BibTeX
@article{Chomean2024,
author = {Chomean, Sirinart and Puttaruk, Palakorn and Khamsophar, Phakawat and Fukpo, Waraphorn and Kaset, Chollanot},
title = {Evaluation of rapid diagnostic test kits for detection of Treponema pallidum antibody},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0303477}
}
EUVIMED